Bravecto 250 mg (Fluralaner SOLUTION) 250 MG

Bravecto 250 mg is a topical solution containing fluralaner, designed for effective flea and tick prevention in pets. This long-lasting treatment offers convenience and reliability for pet owners seeking to protect their animals from common parasites.

Strength

250 MG

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bravecto 250 mg is primarily used for the prevention and treatment of flea and tick infestations in pets. This topical solution is applied directly to the skin and provides extended protection against these parasites. Pet owners often use Bravecto to maintain their animal's comfort and health by preventing bites and infestations.

Side Effects

When applied as directed, Bravecto 250 mg works by targeting the nervous system of fleas and ticks, leading to their paralysis and death. This action helps to break the lifecycle of these parasites, providing long-lasting protection for pets. Some pets may experience mild skin irritation at the application site.

Precautions & Warnings

Always follow the instructions provided by your veterinarian when using Bravecto 250 mg. Ensure the solution is applied to healthy, intact skin and avoid contact with the pet's eyes and mouth. Monitor your pet for any signs of adverse reactions and consult your veterinarian if concerns arise.

Avoid Interactions

Bravecto 250 mg may interact with other topical treatments or medications. It is important to inform your veterinarian about any other products you are using on your pet. Additionally, avoid using this solution in conjunction with other flea and tick treatments unless directed by a veterinarian.

Frequently Asked Questions

Bravecto 250 mg is used for the prevention and treatment of flea and tick infestations in pets. It provides long-lasting protection against these parasites.

The frequency of application depends on your pet's specific needs and the recommendations of your veterinarian. Typically, it is applied every 8 to 12 weeks.

Bravecto 250 mg is generally safe for use in puppies, but it is important to consult your veterinarian to determine the appropriate dosage and usage for your specific pet.

If your pet shows signs of an adverse reaction, such as excessive itching or redness, discontinue use and consult your veterinarian immediately.

Bravecto 250 mg is specifically formulated for dogs and should not be used on cats. Always use products specifically designed for the intended species.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.